APA (7th ed.) Citation

Ling-Chun Chen, Wei-Jie Cheng, Shyr-Yi Lin, Ming-Tse Hung, Ming-Thau Sheu, Hong-Liang Lin, & Chien-Ming Hsieh. (2021). CPT11 with P-glycoprotein/CYP 3A4 dual-function inhibitor by self-nanoemulsifying nanoemulsion combined with gastroretentive technology to enhance the oral bioavailability and therapeutic efficacy against pancreatic adenocarcinomas. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Ling-Chun Chen, Wei-Jie Cheng, Shyr-Yi Lin, Ming-Tse Hung, Ming-Thau Sheu, Hong-Liang Lin, and Chien-Ming Hsieh. CPT11 with P-glycoprotein/CYP 3A4 Dual-function Inhibitor by Self-nanoemulsifying Nanoemulsion Combined with Gastroretentive Technology to Enhance the Oral Bioavailability and Therapeutic Efficacy Against Pancreatic Adenocarcinomas. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Ling-Chun Chen, et al. CPT11 with P-glycoprotein/CYP 3A4 Dual-function Inhibitor by Self-nanoemulsifying Nanoemulsion Combined with Gastroretentive Technology to Enhance the Oral Bioavailability and Therapeutic Efficacy Against Pancreatic Adenocarcinomas. Taylor & Francis Group, 2021.